Brain Boluses each provide 30 minutes of CE credit – 20 minutes of interprofessional education and 10 minutes interacting with pharmacist and physician colleagues on the discussion board. They are aimed at addressing primary care medicine and pharmacy practices through review of the latest medical literature. They're timely, accurate, directly impact your practice, and conveniently delivered to your inbox approximately every other week. Each season will feature 10 episodes. Join today so you don’t miss out on new episodes!
. . .
Season 1 Includes:
S1 E1: The SPRINT Trial Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Compare and contrast the results of the SPRINT study to the JNC-8 guidelines in patients with hypertension
0107-0000-16-112-H01-P 0.05 CEU/0.5 Hr
S1 E2: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes (EMPA-REG Outcomes Study)
Describe the role of empagliflozin in reducing macrovascular complications in DM 2 and the patients with this disease that may benefit from this drug
0107-0000-16-113-H01-P 0.05 CEU/0.5 Hr
S1 E3: Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for Treating Acute Low Back Pain: A Randomized Controlled Trial
Assess the use of skeletal muscle relaxants and opioids in the routine use of low back pain based on this clinical trial
0107-0000-16-114-H01-P 0.05 CEU/0.5 Hr
S1 E4: Effectiveness of Cranberry Capsules to Prevent Urinary Tract Infections in Vulnerable Older Persons
Assess if cranberry juice capsules can reduce urinary tract infections in long term care patients at high risk
0107-0000-16-115-H01-P 0.05 CEU/0.5 Hr
S1 E5: Home Treatment of Deep Venous Thrombosis According to Comorbid Conditions
1. Discuss the relative advantages and disadvantages of treatment of deep venous thrombosis at home
2. Recognize the association of comorbid conditions with the decision to treat this condition in the hospital
3. Recognize the potential cost savings associated with treating deep venous thrombosis at home
0107-0000-16-129-H01-P 0.05 CEU/0.5 Hr
S1 E6: Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Determine the appropriate use of spironolactone in the treatment of resistant hypertension
0107-0000-16-130-H01-P 0.05 CEU/0.5 Hr
S1 E7: Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks
Discuss the role of combination nicotine replacement therapy for smoking cessation
0107-0000-16-131-H01-P 0.05 CEU/0.5 Hr
S1 E8: Oral Prednisolone in the Treatment of Acute Gout
Describe the use of oral corticosteroids in the treatment of acute gouty arthritis attacks
0107-0000-16-137-H01-P 0.05 CEU/0.5 Hr
S1 E9: Outcomes in a Warfarin-Treated Population With Atrial Fibrillation
Discuss the factors associated with high time in therapeutic range (TTR), safety and efficacy in patients with atrial fibrillation using warfarin for stroke prophylaxis
0107-0000-16-138-H01-P 0.05 CEU/0.5 Hr
S1 E10: Effect of Vitamin D Supplementation on Knee Osteoarthritis
Counsel patients considering taking vitamin D for treatment of osteoarthritis (OA)
0107-0000-16-139-H01-P 0.05 CEU/0.5 Hr
Be sure to vote for upcoming topics to ensure they are relevant to what you want to learn!
. . .
Geoffrey C. Wall, PharmD, FCCP, BCPS, CGP
Professor of Pharmacy Practice
Drake University College of Pharmacy and Health Sciences
William John Yost, MD, FACP
University of Iowa- Des Moines Internal Medicine Residency Program
Iowa Methodist Medical Center
UnityPoint Health- Des Moines
Dr. Wall reports he is a speaker’s bureau member for Boehringer Ingelheim, Janssen and The Medicine Co. CEI has taken appropriate action for conflict resolution, including external peer review. Dr. Yost does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education activity.
UnityPoint Health – Des Moines designates this enduring material activity for a maximum of .50 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Financial Support: There was no financial support provided for these activities.
Activity Fee: Brain Bolus Season 1 includes 10 episodes available at only $135 for the complete season. Special group pricing is available. Please contact CEI at 515.270.8118 for more information.